$0.48 Earnings Per Share Expected for Sabra Health Care REIT Inc (NASDAQ:SBRA) This Quarter

Wall Street brokerages expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to report earnings of $0.48 per share for the current quarter, according to Zacks. Three analysts have made estimates for Sabra Health Care REIT’s earnings, with the lowest EPS estimate coming in at $0.46 and the highest estimate coming in at $0.49. Sabra Health Care REIT reported earnings per share of $0.57 in the same quarter last year, which would suggest a negative year over year growth rate of 15.8%. The firm is expected to issue its next quarterly earnings results on Wednesday, August 14th.

On average, analysts expect that Sabra Health Care REIT will report full year earnings of $1.90 per share for the current fiscal year, with EPS estimates ranging from $1.87 to $1.93. For the next financial year, analysts expect that the company will post earnings of $1.93 per share, with EPS estimates ranging from $1.87 to $1.99. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that follow Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, May 8th. The real estate investment trust reported ($0.44) earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.94). Sabra Health Care REIT had a net margin of 23.38% and a return on equity of 4.25%. The business had revenue of $136.77 million for the quarter, compared to the consensus estimate of $144.87 million.

SBRA has been the subject of several recent analyst reports. BidaskClub upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating in a research note on Tuesday, May 14th. Zacks Investment Research upgraded Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Friday, June 21st. Finally, ValuEngine upgraded Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Thursday, March 14th. Two equities research analysts have rated the stock with a sell rating and seven have issued a hold rating to the company. Sabra Health Care REIT presently has an average rating of “Hold” and a consensus price target of $20.71.

Several hedge funds have recently made changes to their positions in the business. First Trust Advisors LP increased its holdings in Sabra Health Care REIT by 37.3% during the 1st quarter. First Trust Advisors LP now owns 113,444 shares of the real estate investment trust’s stock valued at $2,209,000 after purchasing an additional 30,805 shares in the last quarter. FMR LLC increased its holdings in Sabra Health Care REIT by 4.5% during the 1st quarter. FMR LLC now owns 6,095,981 shares of the real estate investment trust’s stock valued at $118,689,000 after purchasing an additional 263,481 shares in the last quarter. Nordea Investment Management AB increased its holdings in Sabra Health Care REIT by 39.7% during the 1st quarter. Nordea Investment Management AB now owns 745,352 shares of the real estate investment trust’s stock valued at $14,512,000 after purchasing an additional 211,698 shares in the last quarter. Advisory Services Network LLC increased its holdings in Sabra Health Care REIT by 158.6% during the 1st quarter. Advisory Services Network LLC now owns 11,663 shares of the real estate investment trust’s stock valued at $227,000 after purchasing an additional 7,153 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC increased its holdings in Sabra Health Care REIT by 491.4% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 2,419 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 2,010 shares in the last quarter. Institutional investors own 89.40% of the company’s stock.

NASDAQ:SBRA traded down $0.24 during mid-day trading on Friday, hitting $19.02. 63,568 shares of the company’s stock traded hands, compared to its average volume of 1,334,560. The firm’s 50 day moving average price is $19.57. Sabra Health Care REIT has a 12 month low of $15.70 and a 12 month high of $23.83. The company has a market capitalization of $3.43 billion, a price-to-earnings ratio of 8.24, a price-to-earnings-growth ratio of 10.70 and a beta of 0.92. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 1.06.

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Shareholders of record on Monday, May 20th were given a $0.45 dividend. The ex-dividend date was Friday, May 17th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 9.46%. Sabra Health Care REIT’s dividend payout ratio is currently 78.60%.

Sabra Health Care REIT Company Profile

As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (“Senior Housing – Leased”), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Recommended Story: Why is Cost of Capital Important?

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.